glyburide has been researched along with Autoimmune Diabetes in 67 studies
Glyburide: An antidiabetic sulfonylurea derivative with actions like those of chlorpropamide
glyburide : An N-sulfonylurea that is acetohexamide in which the acetyl group is replaced by a 2-(5-chloro-2-methoxybenzamido)ethyl group.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Right atrial sections from four patient groups-non-diabetic, insulin-dependent diabetes mellitus (IDDM), non-insulin-dependent diabetes mellitus (NIDDM) receiving glibenclamide, and NIDDM receiving metformin-were subjected to one of the following protocols: aerobic control, simulated ischemia/reoxygenation, ischemic preconditioning before ischemia, and pharmacological preconditioning with alpha 1 agonist phenylephrine, adenosine, the mito-K(ATP) channel opener diazoxide, the protein kinase C (PKC) activator phorbol-12-myristate-13-acetate (PMA), or the p38 mitogen-activated protein kinase (p38MAPK) activator anisomycin." | 3.73 | Mitochondrial dysfunction as the cause of the failure to precondition the diabetic human myocardium. ( Fowler, A; Galiñanes, M; Hassouna, A; Loubani, M; Matata, BM; Standen, NB, 2006) |
| "Glyburide and other sulfonylureas consistently enhance receptor binding in cells from patients with non-insulin-dependent diabetes mellitus, whereas no effects and mixed effects have been demonstrated in cells from patients with insulin-dependent diabetes mellitus and in normal cells, respectively." | 3.67 | Dual actions of sulfonylureas and glyburide. Receptor and post-receptor effects. ( Gavin, JR, 1985) |
| "Alterations in plasma branched-chain amino acids (valine, isoleucine and leucine) and alanine have been described in patients with insulin-dependent diabetes mellitus who have poor metabolic control." | 3.66 | Branched-chain amino acids and alanine as indices of the metabolic control in type 1 (insulin-dependent) and type 2 (non-insulin-dependent) diabetic patients. ( Angiolini, A; Ciavarella, A; Forlani, G; Marchesini, G; Pisi, E; Vannini, P; Zoli, M, 1982) |
| " Therefore, it is apparent that the addition of glibenclamide to insulin reduces daily insulin dosage and renders a greater uniformity to diurnal blood glucose control, most probably secondary to enhancement of insulin sensitivity." | 2.68 | More uniform diurnal blood glucose control and a reduction in daily insulin dosage on addition of glibenclamide to insulin in type 1 diabetes mellitus: role of enhanced insulin sensitivity. ( Birkenholz, M; Kabadi, M; Kabadi, UM; McCoy, S, 1995) |
| "Neonatal diabetes mellitus is rare, may either be transient or permanent, and may be caused by mutations in any of the several different genes." | 1.35 | Outpatient transition of an infant with permanent neonatal diabetes due to a KCNJ11 activating mutation from subcutaneous insulin to oral glyburide. ( Bremer, AA; Lustig, RH; Ranadive, S, 2008) |
| " Dosing of glyburide three times daily was critical for her successful transition." | 1.34 | Transition from insulin to glyburide in a 4-month-old girl with neonatal diabetes mellitus caused by a mutation in KCNJ11. ( Chan, YM; Laffel, LM, 2007) |
| "Significantly more participants with type 2 diabetes using oral drugs than those with type 1 diabetes and using insulin preferred inhaled insulin (98." | 1.33 | Willingness to pay for inhaled insulin: a contingent valuation approach. ( Einarson, TR; Leiter, LA; MacKeigan, LD; Sadri, H, 2005) |
| "IDDM was induced in rats by streptozotocin (STZ) injection, and adequate insulin was provided to maintain moderate hyperglycemia." | 1.31 | Exaggerated impact of ATP-sensitive K(+) channels on afferent arteriolar diameter in diabetes mellitus. ( Bast, JP; Carmines, PK; Fallet, RW; Ikenaga, H, 2000) |
| " Old age, maximum dosage of glibenclamide (15 mg/day) and multimorbidity were characteristic of these patients." | 1.29 | [Incidence of severe hypoglycemia in relation to metabolic control and patient knowledge]. ( Ratzmann, KP; Schimke, E, 1995) |
| "In protocol 1, 10 patients with NIDDM and seven young healthy control subjects were studied." | 1.28 | Effects of glyburide on in vivo insulin-mediated glucose disposal. ( Simonson, DC, 1990) |
| "In the IDDM patients, the addition of glyburide produced no change in daily insulin dose (54 +/- 8 vs." | 1.27 | Effect of glyburide on glycemic control, insulin requirement, and glucose metabolism in insulin-treated diabetic patients. ( Castellino, P; DeFronzo, RA; Delprato, S; Groop, L; Simonson, DC, 1987) |
| "When treated with glyburide, the severity of the mechanical defect was significantly less." | 1.27 | Effect of chronic sulfonylurea treatment on the myocardium of insulin-dependent diabetic rats. ( Mozaffari, MS; Schaffer, SW; Wilson, GL, 1988) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 25 (37.31) | 18.7374 |
| 1990's | 10 (14.93) | 18.2507 |
| 2000's | 20 (29.85) | 29.6817 |
| 2010's | 11 (16.42) | 24.3611 |
| 2020's | 1 (1.49) | 2.80 |
| Authors | Studies |
|---|---|
| He, B | 1 |
| Li, X | 2 |
| Zhou, Z | 1 |
| Heo, JW | 1 |
| Kim, SW | 1 |
| Cho, EH | 1 |
| Babiker, T | 1 |
| Shepherd, MH | 1 |
| Hattersley, AT | 3 |
| Rodríguez-Villar, C | 1 |
| Conget, I | 1 |
| Ferrer-Fàbrega, J | 1 |
| Paredes, D | 1 |
| Ruíz, A | 1 |
| Roque, R | 1 |
| Rull, R | 1 |
| López-Boado, M | 1 |
| Ricart, MJ | 1 |
| Garcia, R | 1 |
| Adalia, R | 1 |
| Rabbone, I | 1 |
| Barbetti, F | 1 |
| Marigliano, M | 1 |
| Bonfanti, R | 1 |
| Piccinno, E | 1 |
| Ortolani, F | 1 |
| Ignaccolo, G | 1 |
| Maffeis, C | 1 |
| Confetto, S | 1 |
| Cerutti, F | 1 |
| Zanfardino, A | 1 |
| Iafusco, D | 1 |
| Cao, B | 1 |
| Gong, C | 1 |
| Wu, D | 1 |
| Lu, C | 1 |
| Liu, F | 1 |
| Liu, X | 1 |
| Zhang, Y | 1 |
| Gu, Y | 2 |
| Qi, Z | 1 |
| Liu, M | 2 |
| Li, W | 1 |
| Su, C | 1 |
| Liang, X | 1 |
| Feng, M | 1 |
| Lamprianou, S | 1 |
| Gysemans, C | 1 |
| Bou Saab, J | 1 |
| Pontes, H | 1 |
| Mathieu, C | 1 |
| Meda, P | 1 |
| Wagner, VM | 1 |
| Kremke, B | 1 |
| Hiort, O | 1 |
| Flanagan, SE | 1 |
| Pearson, ER | 1 |
| Støy, J | 1 |
| Greeley, SA | 1 |
| Paz, VP | 1 |
| Ye, H | 1 |
| Pastore, AN | 1 |
| Skowron, KB | 1 |
| Lipton, RB | 1 |
| Cogen, FR | 1 |
| Bell, GI | 1 |
| Philipson, LH | 1 |
| Esmatjes, E | 1 |
| Jimenez, A | 1 |
| Diaz, G | 1 |
| Mora, M | 1 |
| Casamitjana, R | 1 |
| Pérez de Nanclares, G | 1 |
| Castaño, L | 1 |
| José Ricart, M | 1 |
| Lauridsen, MH | 1 |
| Boesgaard, TW | 1 |
| Pedersen, OB | 1 |
| Hansen, T | 1 |
| Hertz, B | 1 |
| Mohamadi, A | 1 |
| Clark, LM | 1 |
| Lipkin, PH | 1 |
| Mahone, EM | 1 |
| Wodka, EL | 1 |
| Plotnick, LP | 1 |
| Ting, WH | 1 |
| Huang, CY | 1 |
| Lo, FS | 1 |
| Lee, HC | 1 |
| Lin, CL | 1 |
| Guo, WL | 1 |
| Lee, YJ | 1 |
| Jones, AG | 1 |
| D'Aleo, V | 1 |
| Del Guerra, S | 1 |
| Groves, C | 1 |
| Lupi, R | 1 |
| Tancredi, M | 1 |
| McCarthy, M | 1 |
| Marchetti, P | 1 |
| Ballas, J | 1 |
| Moore, TR | 1 |
| Ramos, GA | 1 |
| Sang, Y | 1 |
| Ni, G | 1 |
| Cabrera-Rode, E | 1 |
| Perich, P | 1 |
| Diaz-Horta, O | 1 |
| Tiberti, C | 1 |
| Molina, G | 1 |
| Arranz, C | 1 |
| Martin, JM | 1 |
| Licea, M | 1 |
| De Leiva, AD | 1 |
| Puig-Domingo, M | 1 |
| Dimario, U | 1 |
| Østergård, T | 1 |
| Degn, KB | 1 |
| Gall, MA | 1 |
| Carr, RD | 1 |
| Veldhuis, JD | 1 |
| Thomsen, MK | 1 |
| Rizza, RA | 1 |
| Schmitz, O | 1 |
| Riddle, MC | 2 |
| Codner, E | 1 |
| Flanagan, S | 1 |
| Ellard, S | 1 |
| García, H | 1 |
| Bisseling, TM | 1 |
| Versteegen, MG | 1 |
| van der Wal, S | 1 |
| Copius Peereboom-Stegeman, JJ | 1 |
| Borggreven, JM | 1 |
| Steegers, EA | 1 |
| van der Laak, JA | 1 |
| Russel, FG | 1 |
| Smits, P | 1 |
| Koster, JC | 1 |
| Remedi, MS | 1 |
| Dao, C | 1 |
| Nichols, CG | 1 |
| Hassouna, A | 1 |
| Loubani, M | 1 |
| Matata, BM | 1 |
| Fowler, A | 1 |
| Standen, NB | 1 |
| Galiñanes, M | 1 |
| Sadri, H | 1 |
| MacKeigan, LD | 1 |
| Leiter, LA | 1 |
| Einarson, TR | 1 |
| Chan, YM | 1 |
| Laffel, LM | 1 |
| Letha, S | 1 |
| Mammen, D | 1 |
| Valamparampil, JJ | 1 |
| Bremer, AA | 1 |
| Ranadive, S | 1 |
| Lustig, RH | 1 |
| Bieger, WP | 1 |
| Dlugosch, R | 1 |
| Rettenmeier, A | 1 |
| Holler, HD | 1 |
| Bert, H | 1 |
| Schwarz, W | 1 |
| Fiehn, W | 1 |
| Merkt, J | 1 |
| Weicker, H | 1 |
| Burke, BJ | 2 |
| Hartog, M | 1 |
| Waterfield, MR | 1 |
| Vannini, P | 1 |
| Marchesini, G | 1 |
| Forlani, G | 1 |
| Angiolini, A | 1 |
| Ciavarella, A | 1 |
| Zoli, M | 1 |
| Pisi, E | 1 |
| Ratzmann, KP | 1 |
| Schimke, E | 1 |
| Olsen, KM | 1 |
| Kearns, GL | 1 |
| Kemp, SF | 1 |
| Hauner, H | 1 |
| Ziegler, O | 1 |
| Guerci, B | 1 |
| Algan, M | 1 |
| Lonchamp, P | 1 |
| Weber, M | 1 |
| Drouin, P | 1 |
| Kabadi, UM | 1 |
| McCoy, S | 1 |
| Birkenholz, M | 1 |
| Kabadi, M | 1 |
| Ladis, V | 1 |
| Theodorides, C | 1 |
| Palamidou, F | 1 |
| Frissiras, S | 1 |
| Berdousi, H | 1 |
| Kattamis, C | 1 |
| Sharma, A | 1 |
| Kharb, S | 1 |
| Chugh, SN | 1 |
| Kakkar, R | 1 |
| Singh, GP | 1 |
| Sasakuma, F | 1 |
| Shimizu, T | 1 |
| Wada, H | 1 |
| Morii, T | 1 |
| Sasaki, A | 1 |
| Ehara, M | 1 |
| Ikenaga, H | 1 |
| Bast, JP | 1 |
| Fallet, RW | 1 |
| Carmines, PK | 1 |
| Fedorchenko, IuL | 1 |
| Goncharova, EN | 1 |
| Koblova, NM | 1 |
| Fallucca, F | 1 |
| Iavicoli, M | 1 |
| Menzinger, G | 1 |
| Mirabella, C | 1 |
| Andreani, D | 1 |
| Willms, B | 1 |
| Wildenhoff, KE | 1 |
| Beischer, W | 1 |
| Heinze, E | 1 |
| Keller, L | 1 |
| Raptis, S | 1 |
| Kerner, W | 1 |
| Pfeiffer, EF | 1 |
| Atiea, JA | 1 |
| Luzio, S | 1 |
| Owens, DR | 1 |
| Gums, JG | 1 |
| Curry, RW | 1 |
| Montes de Oca, G | 1 |
| Skluth, HA | 1 |
| Reynolds, LR | 1 |
| Stålhammar, J | 1 |
| Bergman, U | 1 |
| Boman, K | 1 |
| Dahlén, M | 1 |
| Simonson, DC | 2 |
| Hart, JS | 1 |
| Bouma, DJ | 1 |
| Phillipson, BE | 1 |
| Youker, G | 1 |
| Khristov, V | 1 |
| Nikolov, M | 1 |
| Delprato, S | 1 |
| Castellino, P | 1 |
| Groop, L | 1 |
| DeFronzo, RA | 1 |
| Garrel, DR | 1 |
| Picq, R | 1 |
| Bajard, L | 1 |
| Harfouche, M | 1 |
| Tourniaire, J | 1 |
| Larkins, RG | 1 |
| Jerums, G | 1 |
| Taft, JL | 1 |
| Godfrey, H | 1 |
| Smith, IL | 1 |
| Martin, TJ | 1 |
| Stocks, AE | 1 |
| Ma, A | 1 |
| Howlett, V | 1 |
| Cameron, DP | 1 |
| Mozaffari, MS | 1 |
| Wilson, GL | 1 |
| Schaffer, SW | 1 |
| Pernet, A | 1 |
| Trimble, ER | 1 |
| Kuntschen, F | 1 |
| Assal, JP | 1 |
| Hahn, C | 1 |
| Renold, AE | 1 |
| Gerich, JE | 1 |
| Gavin, JR | 1 |
| Kostner, GM | 1 |
| Schernthaner, G | 1 |
| Tattersall, RB | 1 |
| Cicognani, A | 1 |
| Tassoni, P | 1 |
| Pirazzoli, P | 1 |
| Collina, A | 1 |
| Cacciari, E | 1 |
| Weber, B | 2 |
| Stratmann, FW | 1 |
4 reviews available for glyburide and Autoimmune Diabetes
| Article | Year |
|---|---|
Continuous spectrum of glucose dysmetabolism due to the KCNJ11 gene mutation-Case reports and review of the literature.
Topics: Adolescent; Base Sequence; Blood Glucose; Child; Diabetes Mellitus, Type 1; DNA Mutational Analysis; | 2021 |
Management of diabetes in pregnancy.
Topics: Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetes, Gestational; Female; Glyburide; Huma | 2012 |
Timely initiation of basal insulin.
Topics: Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Disease Progression; Drug Therapy, Combination | 2004 |
Sulfonylureas in the treatment of diabetes mellitus--1985.
Topics: Blood Glucose; Body Weight; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Drug Therapy, Comb | 1985 |
12 trials available for glyburide and Autoimmune Diabetes
| Article | Year |
|---|---|
Slowly progressing type 1 diabetes: persistence of islet cell autoantibodies is related to glibenclamide treatment.
Topics: Autoantibodies; Blood Glucose; Body Mass Index; C-Peptide; Diabetes Mellitus, Type 1; Diabetes Melli | 2002 |
The insulin secretagogues glibenclamide and repaglinide do not influence growth hormone secretion in humans but stimulate glucagon secretion during profound insulin deficiency.
Topics: Blood Glucose; C-Peptide; Carbamates; Diabetes Mellitus, Type 1; Fatty Acids, Nonesterified; Glucago | 2004 |
Trial of sulfonylurea in combination with insulin in the therapy of diabetes type I and II. Evidence against a primary extrapancreatic receptor effect.
Topics: Adult; Binding, Competitive; Blood Glucose; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Do | 1984 |
Improved diabetic control in insulin-dependent diabetics treated with insulin and glibenclamide.
Topics: Adult; Blood Glucose; C-Peptide; Clinical Trials as Topic; Diabetes Mellitus, Type 1; Double-Blind M | 1984 |
More uniform diurnal blood glucose control and a reduction in daily insulin dosage on addition of glibenclamide to insulin in type 1 diabetes mellitus: role of enhanced insulin sensitivity.
Topics: Adult; Aged; Blood Glucose; Body Weight; C-Peptide; Cholesterol; Circadian Rhythm; Cross-Over Studie | 1995 |
Evaluation of oxidative stress before and after control of glycemia and after vitamin E supplementation in diabetic patients.
Topics: Adult; Blood Glucose; Diabetes Mellitus; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Femal | 2000 |
Treatment of type I diabetes with a combination of glyburide and insulin.
Topics: Adolescent; Adult; Aged; Blood Glucose; Diabetes Mellitus, Type 1; Double-Blind Method; Drug Therapy | 1992 |
Efficacy of bedtime NPH insulin with daytime sulfonylurea for subpopulation of type II diabetic subjects.
Topics: Adult; Aged; Blood Glucose; C-Peptide; Clinical Trials as Topic; Diabetes Mellitus, Type 1; Double-B | 1989 |
Lack of effect of gliclazide on platelet aggregation in insulin-treated and non-insulin-treated diabetes: a two-year controlled study.
Topics: Clinical Trials as Topic; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Angiopathie | 1988 |
Lack of effect of glibenclamide on insulin requirements and diabetic control in persons with insulin-dependent diabetes.
Topics: Adult; Blood Glucose; Clinical Trials as Topic; Diabetes Mellitus, Type 1; Double-Blind Method; Drug | 1988 |
Sulphonylurea and insulin: combined treatment in type 1 (insulin-dependent) diabetes.
Topics: C-Peptide; Clinical Trials as Topic; Diabetes Mellitus, Type 1; Double-Blind Method; Drug Therapy, C | 1985 |
Oral substitutes for insulin: modern appraisal of their action and indications.
Topics: Adolescent; Adult; Aged; Animals; Blood Glucose; Diabetes Mellitus; Diabetes Mellitus, Type 1; Diet, | 1972 |
51 other studies available for glyburide and Autoimmune Diabetes
| Article | Year |
|---|---|
Unsuccessful switch from insulin to sulfonylurea therapy in permanent neonatal diabetes mellitus due to an R201H mutation in the KCNJ11 gene: a case report.
Topics: Administration, Oral; Adolescent; Arginine; Blood Glucose; Diabetes Mellitus, Type 1; Glyburide; Gly | 2013 |
Continue with long term sulfonylureas in patients with mutations in the KCNJ11 gene when there is evidence of response even if insulin treatment is still required.
Topics: Diabetes Mellitus, Type 1; Glyburide; Humans; Hypoglycemic Agents; Insulin; Male; Mutation, Missense | 2013 |
Successful Pancreas Transplantation From a Deceased Donor Intoxicated With Oral Antidiabetic Agent: A Case Report.
Topics: Diabetes Mellitus, Type 1; Diabetic Nephropathies; Drug Overdose; Female; Glyburide; Humans; Hypogly | 2015 |
Successful treatment of young infants presenting neonatal diabetes mellitus with continuous subcutaneous insulin infusion before genetic diagnosis.
Topics: Blood Glucose; C-Peptide; Diabetes Mellitus; Diabetes Mellitus, Type 1; Female; Glyburide; Humans; H | 2016 |
Genetic Analysis and Follow-Up of 25 Neonatal Diabetes Mellitus Patients in China.
Topics: Blood Glucose; China; Diabetes Mellitus, Type 1; Female; Follow-Up Studies; Genotype; Glyburide; Gly | 2016 |
Glibenclamide Prevents Diabetes in NOD Mice.
Topics: Animals; Cells, Cultured; Cytokines; Diabetes Mellitus, Type 1; Female; Glyburide; Hypoglycemic Agen | 2016 |
Transition from insulin to sulfonylurea in a child with diabetes due to a mutation in KCNJ11 encoding Kir6.2--initial and long-term response to sulfonylurea therapy.
Topics: Blood Glucose; Child; Diabetes Mellitus, Type 1; Glyburide; Glycated Hemoglobin; Heterozygote; Human | 2009 |
Diagnosis and treatment of neonatal diabetes: a United States experience.
Topics: Adolescent; Adult; ATP-Binding Cassette Transporters; Child; Child, Preschool; Diabetes Complication | 2008 |
Neonatal diabetes with end-stage nephropathy: pancreas transplantation decision.
Topics: Adult; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Follow-Up Studies; Glyburide; Humans; Hypo | 2008 |
[Diabetes in infants may be treated with sulfonylurea as a replacement for insulin].
Topics: Child, Preschool; Diabetes Mellitus, Type 1; Diabetic Ketoacidosis; Female; Glyburide; Humans; Hypog | 2009 |
Medical and developmental impact of transition from subcutaneous insulin to oral glyburide in a 15-yr-old boy with neonatal diabetes mellitus and intermediate DEND syndrome: extending the age of KCNJ11 mutation testing in neonatal DM.
Topics: Administration, Oral; Adolescent; Continuity of Patient Care; Developmental Disabilities; Diabetes M | 2010 |
Improved diabetic control during oral sulfonylurea treatment in two children with permanent neonatal diabetes mellitus.
Topics: Adolescent; Blood Glucose; C-Peptide; Child; Diabetes Mellitus, Type 1; DNA Mutational Analysis; Dru | 2009 |
Reevaluation of a case of type 1 diabetes mellitus diagnosed before 6 months of age.
Topics: Administration, Oral; Adolescent; Amino Acid Substitution; Developmental Disabilities; Diabetes Mell | 2010 |
INS VNTR class genotype and the function of isolated human islets.
Topics: Aged; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Female; Gene Expression Regulation; Gene | 2011 |
AV59M KCNJ11 gene mutation leading to intermediate DEND syndrome in a Chinese child.
Topics: Asian People; Developmental Disabilities; Diabetes Mellitus, Type 1; Glyburide; Humans; Hypoglycemic | 2011 |
High-dose glibenclamide can replace insulin therapy despite transitory diarrhea in early-onset diabetes caused by a novel R201L Kir6.2 mutation.
Topics: Amino Acid Substitution; Diabetes Mellitus, Type 1; Diarrhea; Female; Glyburide; Humans; Hypoglycemi | 2005 |
Impaired KATP channel function in the fetoplacental circulation of patients with type 1 diabetes mellitus.
Topics: 4-Aminopyridine; Charybdotoxin; Diabetes Mellitus, Type 1; Endothelial Cells; Female; Glyburide; Hum | 2005 |
ATP and sulfonylurea sensitivity of mutant ATP-sensitive K+ channels in neonatal diabetes: implications for pharmacogenomic therapy.
Topics: Adenosine Triphosphate; Animals; Cell Line; Diabetes Mellitus, Type 1; Glyburide; Humans; Hypoglycem | 2005 |
Mitochondrial dysfunction as the cause of the failure to precondition the diabetic human myocardium.
Topics: Adenosine; Adrenergic alpha-Agonists; Diabetes Mellitus; Diabetes Mellitus, Type 1; Diabetes Mellitu | 2006 |
Willingness to pay for inhaled insulin: a contingent valuation approach.
Topics: Administration, Inhalation; Administration, Oral; Adult; Canada; Diabetes Mellitus, Type 1; Diabetes | 2005 |
Transition from insulin to glyburide in a 4-month-old girl with neonatal diabetes mellitus caused by a mutation in KCNJ11.
Topics: Diabetes Mellitus, Type 1; Female; Glyburide; Humans; Hypoglycemic Agents; Infant; Insulin; Potassiu | 2007 |
Permanent neonatal diabetes due to KCNJ11 gene mutation.
Topics: Acute Kidney Injury; Amino Acid Substitution; Arginine; Blood Glucose; Cysteine; Diabetes Mellitus, | 2007 |
Outpatient transition of an infant with permanent neonatal diabetes due to a KCNJ11 activating mutation from subcutaneous insulin to oral glyburide.
Topics: Birth Weight; Diabetes Mellitus; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Female; Glybu | 2008 |
Branched-chain amino acids and alanine as indices of the metabolic control in type 1 (insulin-dependent) and type 2 (non-insulin-dependent) diabetic patients.
Topics: Alanine; Amino Acids, Branched-Chain; Blood Glucose; Diabetes Mellitus; Diabetes Mellitus, Type 1; F | 1982 |
[Incidence of severe hypoglycemia in relation to metabolic control and patient knowledge].
Topics: Adult; Aged; Blood Glucose Self-Monitoring; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Do | 1995 |
Glyburide protein binding and the effect of albumin glycation in children, young adults, and older adults with diabetes.
Topics: Adolescent; Adult; Aged; Blood Glucose; Child; Child, Preschool; Diabetes Mellitus, Type 1; Diabetes | 1995 |
[Insulin, glibenclamide plus acarbose in diabetes mellitus?].
Topics: Acarbose; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Glyburide | 1995 |
Improved visual evoked potential latencies in poorly controlled diabetic patients after short-term strict metabolic control.
Topics: Adult; Blood Glucose; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Evoked Potentials, Visua | 1994 |
Regulation of glucose disturbances with glibenclamide in patients with thalassemia.
Topics: Adolescent; Adult; beta-Thalassemia; Blood Glucose; Child; Diabetes Mellitus, Type 1; Female; Glucos | 1998 |
Human anti-murine antibodies interfere with CPR assays performed with commercial kits.
Topics: Aged; Animals; Antibodies; Antibodies, Monoclonal; Artifacts; C-Peptide; Child, Preschool; Diabetes | 2000 |
Exaggerated impact of ATP-sensitive K(+) channels on afferent arteriolar diameter in diabetes mellitus.
Topics: Adenosine Triphosphate; Animals; Arterioles; Benzopyrans; Cyclopentanes; Diabetes Mellitus, Experime | 2000 |
[Proliferative activity of the gastric epithelium: changes due to therapy in patients with association of gastric ulcer and diabetes mellitus].
Topics: Adult; Age Factors; Aged; Data Interpretation, Statistical; Diabetes Complications; Diabetes Mellitu | 2001 |
Glucagon and growth hormone secretion in insulin-treated diabetics: effects of added sulfonylureas.
Topics: Adult; Arginine; Diabetes Mellitus, Type 1; Female; Glucagon; Glyburide; Growth Hormone; Humans; Ins | 1978 |
[The importance of serum insulin determination in the diagnosis and treatment of diabetes mellitus (author's transl)].
Topics: Blood Glucose; Diabetes Mellitus; Diabetes Mellitus, Type 1; Diet Therapy; Dose-Response Relationshi | 1975 |
Blood ketone body disappearance rate in diabetics and normals after rapid infusion of dl-3-hydroxybutyrate. Studies before and after diabetic treatment.
Topics: Acetoacetates; Adolescent; Adult; Aged; Blood Glucose; Diabetes Mellitus; Diabetes Mellitus, Type 1; | 1976 |
Human C-peptide. Part II: Clinical studies.
Topics: C-Peptide; Chromatography, Gel; Diabetes Mellitus; Diabetes Mellitus, Type 1; Glucose; Glyburide; Hu | 1976 |
The dawn phenomenon and diabetes control in treated NIDDM and IDDM patients.
Topics: Blood Glucose; Circadian Rhythm; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Female; Gluca | 1992 |
Metabolic control in diabetic subjects in three Swedish areas with high, medium, and low sales of antidiabetic drugs.
Topics: Administration, Oral; Aged; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Drug Therapy, Comb | 1991 |
Effects of glyburide on in vivo insulin-mediated glucose disposal.
Topics: Adult; Blood Glucose; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Glucose; Glyburide; Huma | 1990 |
[The correlation of glycohemoglobin (HbA1) with the parameters of blood glucose control during the treatment of diabetes mellitus].
Topics: Adult; Blood Glucose; Chronic Disease; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Drug Th | 1989 |
Effect of glyburide on glycemic control, insulin requirement, and glucose metabolism in insulin-treated diabetic patients.
Topics: Adult; Blood Glucose; C-Peptide; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Female; Glybu | 1987 |
Acute effect of glyburide on insulin sensitivity in type I diabetic patients.
Topics: Blood Glucose; Diabetes Mellitus, Type 1; Drug Synergism; Glyburide; Humans; Insulin; Osmolar Concen | 1987 |
Effect of chronic sulfonylurea treatment on the myocardium of insulin-dependent diabetic rats.
Topics: Animals; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Glucose; Glucose Tolerance Test | 1988 |
Sulfonylureas in insulin-dependent (type I) diabetes: evidence for an extrapancreatic effect in vivo.
Topics: Adult; Blood Glucose; C-Peptide; Diabetes Mellitus, Type 1; Glucose; Glyburide; Humans; Hypoglycemic | 1985 |
Dual actions of sulfonylureas and glyburide. Receptor and post-receptor effects.
Topics: Adipose Tissue; Animals; Cells, Cultured; Diabetes Mellitus; Diabetes Mellitus, Type 1; Diabetes Mel | 1985 |
Apolipoproteins in diabetes mellitus.
Topics: Adult; Apolipoproteins; Bezafibrate; Diabetes Mellitus; Diabetes Mellitus, Type 1; Diabetes Mellitus | 1985 |
Mild familial diabetes with dominant inheritance.
Topics: Acetohexamide; Adolescent; Adult; Aged; Blood Glucose; Carbohydrates; Child; Chlorpropamide; Diabete | 1974 |
[Infantile diabetes and treatment with oral hypoglycemizing agents (function tests of the endocrine pancreatic before and after one year of therapy)].
Topics: Child; Child, Preschool; Diabetes Mellitus, Type 1; Female; Glucose Tolerance Test; Glyburide; Human | 1972 |
Glucose-stimulated insulin secretion during "remission" of juvenile diabetes.
Topics: Blood Glucose; Child; Diabetes Mellitus, Type 1; Diet, Diabetic; Glucose Tolerance Test; Glyburide; | 1972 |
Insulin release in children with diet-treated diabetes.
Topics: Adolescent; Blood Glucose; Child; Child, Preschool; Diabetes Mellitus, Type 1; Diabetic Ketoacidosis | 1972 |
[HB 419 (glibenclamide) and possibilities of its combinations in the treatment of diabetes mellitus].
Topics: Diabetes Mellitus; Diabetes Mellitus, Type 1; Drug Synergism; Glyburide; Humans; Insulin; Sulfonylur | 1970 |